Victory Capital Management
ARRY

Victory Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Victory Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,930
Closed -$71K – 1879
2019
Q1 		$71K Hold
2,930
– – ﹤0.01% 1682
2018
Q4 		$42K Sell
2,930
-558
-16% -$8.46K ﹤0.01% 1708
2018
Q3 		$53K Buy
3,488
+458
+15% +$7.02K ﹤0.01% 1724
2018
Q2 		$51K Sell
3,030
-62,010
-95% -$986K ﹤0.01% 1758
2018
Q1 		$1.06M Buy
65,040
+62,010
+2,047% +$993K ﹤0.01% 1229
2017
Q4 		$39K Hold
3,030
– – ﹤0.01% 1762
2017
Q3 		$37K Sell
3,030
-107,968
-97% -$1M ﹤0.01% 1756
2017
Q2 		$929K Sell
110,998
-1,860
-2% -$15.2K ﹤0.01% 1203
2017
Q1 		$1.01M Buy
+112,858
New +$1.2M ﹤0.01% 1170

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return